This cooperative agreement funds resource centers and interdisciplinary translational projects focused on tissue engineering and regenerative medicine. It supports validation, manufacturing, preclinical testing, and regulatory preparation of products for detecting or treating tissue damage. The goal is to enable first-in-human clinical studies with approved products and associated protocols.
Eligible applicants include county, state, city, and tribal governments, public and private higher education institutions, nonprofits, small businesses, and for-profit organizations other than small businesses. Specific eligibility details are provided in the full announcement.
